Tilray Brands (TLRY) Revenue (QoQ) (2017 - 2026)
Tilray Brands (TLRY) Revenue (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Tilray Brands | 541.05 Mn | 306.41 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 36.27% |
| Feb 28, 2026 | -4.95% |
| Nov 30, 2025 | 3.82% |
| Aug 31, 2025 | -6.70% |
| May 31, 2025 | 20.86% |
| Feb 28, 2025 | -11.93% |
| Nov 30, 2024 | 5.45% |
| Aug 31, 2024 | -12.98% |
| May 31, 2024 | 22.06% |
| Feb 29, 2024 | -2.80% |
| Nov 30, 2023 | 9.51% |
| Aug 31, 2023 | -3.93% |
| May 31, 2023 | 26.51% |
| Feb 28, 2023 | 1.01% |
| Nov 30, 2022 | -5.92% |
| Aug 31, 2022 | -0.07% |
| May 31, 2022 | 0.96% |
| Feb 28, 2022 | -2.12% |
| Nov 30, 2021 | -7.66% |
| Aug 31, 2021 | 18.13% |